World of DTC Marketing
AUGUST 19, 2022
The Inflation Reduction Act’s health insurance subsidies and drug pricing reforms will improve health care affordability for Americans but won’t do a damn thing for our overall healthcare costs, which will keep rising. A staggering 85% of healthcare costs in the U.S. Finally, there are healthcare administrative costs.
Scott’s Directories
APRIL 30, 2022
The healthcare industry is pretty competitive, recording massive growth yearly. The spending in the healthcare industry increases by millions of dollars every year. Based on this, some B2B healthcare marketers may find it challenging to get the traction they need. These social platforms allow B2B marketers to run ads.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarivate
APRIL 18, 2024
Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare. billion, following an earlier failed healthcare venture with Berkshire Hathaway and JPMorgan Chase.
Clarivate
APRIL 24, 2023
healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. CVS’ bid for Oak Street is in keeping with nearly two decades of evolution toward becoming an integrated payer and provider.
Clarivate
JANUARY 23, 2024
Figure 1 illustrates the trend in the number of NMEs first launched onto the world market between 2013 and 2022. In fact, the number of NMEs has grown by 65% between 2013 and 2022. Looking at NMEs launched globally in 2022 paints a gloomy picture at first sight, with a 28% drop from 2021 to 2022.
Clarify Health
MARCH 17, 2023
trillion dollars are spent annually on US healthcare costs and, of this amount, 31% is provided for hospital services. In recent years, public policy and health economics researchers have used what data was available regarding commercially negotiated payment rates to investigate markups by hospitals and other healthcare providers.
Pharmaceutical Technology
OCTOBER 5, 2022
In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs. BIIB107 is a monoclonal antibody that targets ?4
Expert insights. Personalized for you.
204 
Let's personalize your content